Imatinib interferes with survival of multi drug resistant Kaposi's sarcoma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Imatinib interferes with survival of multi drug resistant Kaposi's sarcoma cells

Published:2007-12-03 Issue:30 Volume:581 Page:5897-5903
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:

Author:

Basciani Sabrina,Vona Rosa,Matarrese Paola,Ascione Barbara,Mariani Stefania,Gnessi Lucio,Malorni Walter,Straface Elisabetta

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.febslet.2007.11.069/fullpdf

Reference22 articles.

1. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug;Capdeville;Nat. Rev. Drug. Discov.,2002

2. Role of KIT and platelet-derived growth factor receptors as oncoproteins;Fletcher;Sem. Oncol.,2004

3. Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies;Heinrich;J. Clin. Oncol.,2002

4. Emerging targets and novel strategies in the treatment of AIDS-related Kaposi’s sarcoma: bidirectional translational science;Dezube;J. Cell Physiol.,2006

5. Imatinib-induced regression of AIDS-related Kaposi’s sarcoma;Koon;J. Clin. Oncol.,2005

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kaposi Sarcoma;Rook's Textbook of Dermatology;2024-03-19

2. Berberine Induces Combined Cell Death in Gastrointestinal Cell Lines;International Journal of Molecular Sciences;2023-04-01

3. Autophagy: a potential key contributor to the therapeutic action of mesenchymal stem cells;Autophagy;2019-06-18

4. Co-delivery of doxorubicin and imatinib by pH sensitive cleavable PEGylated nanoliposomes with folate-mediated targeting to overcome multidrug resistance;International Journal of Pharmaceutics;2018-05

5. Autophagy: Cell death or survive mechanism;Journal of Oncological Sciences;2017-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3